Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention ...

Data from 11 participants demonstrates tegoprubart successfully prevented kidney transplant rejection and was generally safe and well-tolerated

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Canada ,United Kingdom ,Vancouver ,British Columbia ,Australia ,Irvine ,California ,American ,British ,Steve Perrin ,Stephen Jasper ,David Alexandrec Gros ,Johns Gill ,Berry Company Public Relations ,Twitter ,Eledon Pharmaceuticals ,Company Phase ,Linkedin ,Eledon Pharmaceuticals Inc ,University Of British Columbia ,American Society Of Nephrology Kidney Week ,Exchange Commission ,Gilmartin Group ,American Society ,Nephrology Kidney Week ,Chief Executive ,Principal Investigator ,Chief Scientific Officer ,Investor Relations ,Private Securities Litigation Reform Act ,Region ,